Saba Capital Management’s Science Strategic Acquisition Corp. Alpha Class A Common Stock SSAA Stock Holding History

Saba Capital Management’s Portfolio SSAA Stock Details SSAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,396,340	Closed	-$23.6M	–	1102
2022 Q3	$23.6M	Buy	2,396,340 +759,417	+46%	+$7.48M	0.27%	62
2022 Q2	$16.1M	Buy	1,636,923 +193,320	+13%	+$1.9M	0.19%	153
2022 Q1	$14.2M	Buy	1,443,603 +690,076	+92%	+$6.73M	0.2%	136
2021 Q4	$7.35M	Hold	753,527	–	–	0.11%	265
2021 Q3	$7.32M	Buy	753,527 +339,650	+82%	+$3.3M	0.18%	154
2021 Q2	$4.01M	Buy	413,877 +123,289	+42%	+$1.21M	0.11%	190
2021 Q1	$2.79M	Buy	+290,588	New	+$2.84M	0.09%	179

Saba Capital Management's SSAA Position: Q4 2022 in Review

Saba Capital Management sold out of Science Strategic Acquisition Corp. Alpha Class A Common Stock (SSAA) in Q4 2022, closing a stake of 2,396,340 shares — an estimated $23.6M sold.

Saba Capital Management first reported a position in SSAA in Q1 2021 and held it in 7 quarters. The position peaked at $23.6M in Q3 2022. 0 funds tracked by Wall St. Rank hold SSAA as of Q4 2022.

Saba Capital Management reported no remaining Science Strategic Acquisition Corp. Alpha Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Saba Capital Management sold 2,396,340 Science Strategic Acquisition Corp. Alpha Class A Common Stock shares in Q4 2022, an estimated $23.6M.
Saba Capital Management first reported a position in Science Strategic Acquisition Corp. Alpha Class A Common Stock in Q1 2021 and held it in 7 quarters.
Saba Capital Management's Science Strategic Acquisition Corp. Alpha Class A Common Stock position peaked at $23.6M in Q3 2022.
0 funds tracked by Wall St. Rank held Science Strategic Acquisition Corp. Alpha Class A Common Stock as of Q4 2022.

Based on Saba Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.